Kim Yeong-Sang, Song Rita, Chung Hyun Cheol, Jun Moo Jin, Sohn Youn Soo
Department of Chemistry, Ewha Womans University, Seoul 120-750, Republic of Korea.
J Inorg Biochem. 2004 Jan;98(1):98-104. doi: 10.1016/j.jinorgbio.2003.09.004.
The trans-(+/-)-1,2-diaminocyclohexaneplatinum(II) complexes of multidentate L-glutamate (Glu) and L-aspartate (Asp) were prepared and their antitumor activity was examined in relation with their coordination modes. All these complexes were obtained as a mixture of (O,O')- and (O,N)-chelate isomers due to rapid isomerization of the initially formed (O,O')-isomer to the thermodynamically more stable (O,N)-isomer. The (O,O')/(O,N)-isomeric mixture with the mole ratio of 80/20 exhibited excellent antitumor activity while the pure (O,N)-isomer was only marginally active. Therefore, in order to prevent the linkage isomerization of the active (O,O')-isomer to the inactive (O,N)-isomer, we have designed N-substituted amino dicarboxylic acids as a leaving group and prepared a new series of complexes, [Pt(dach)(RGlu)] and [Pt(dach)(RAsp)] (dach=trans-(+/-)-1,2-diaminocyclohexane; R=acetyl (Ac), propionyl (Pro), pivaloyl (Piv), carbobenzyloxy (Cbz) or phthaloyl (Phth)) and characterized by means of elemental analyses, and 1H NMR, 195Pt NMR and IR spectroscopies. The N-substituted amino dicarboxylate ligands were found to coordinate to platinum(II) ion through only the (O,O')-chelation mode, and their Pt(II) complexes were chemically stable in aqueous solution. The present Pt(II) complexes of N-substituted amino dicarboxylic acids showed excellent antitumor activity against both murine leukemia L1210 and human tumor cells. Especially, the highly hydrophobic N-phthaloylglutamate complex, [Pt(dach)(PhthGlu)], exhibited an outstanding in vitro activity (IC50=2.22 microM) on the human stomach cancer cells which are not responsive to cisplatin and carboplatin.
制备了多齿L-谷氨酸(Glu)和L-天冬氨酸(Asp)的反式-(+/-)-1,2-二氨基环己烷铂(II)配合物,并研究了它们的抗肿瘤活性与其配位模式的关系。由于最初形成的(O,O')-异构体迅速异构化为热力学上更稳定的(O,N)-异构体,所有这些配合物均以(O,O')-和(O,N)-螯合异构体的混合物形式获得。摩尔比为80/20的(O,O')/(O,N)-异构体混合物表现出优异的抗肿瘤活性,而纯(O,N)-异构体仅具有微弱活性。因此,为了防止活性(O,O')-异构体向无活性(O,N)-异构体的键合异构化,我们设计了N-取代氨基二羧酸作为离去基团,并制备了一系列新的配合物,[Pt(dach)(RGlu)]和[Pt(dach)(RAsp)](dach = 反式-(+/-)-1,2-二氨基环己烷;R = 乙酰基(Ac)、丙酰基(Pro)、新戊酰基(Piv)、苄氧羰基(Cbz)或邻苯二甲酰基(Phth)),并通过元素分析、1H NMR、195Pt NMR和红外光谱进行了表征。发现N-取代氨基二羧酸酯配体仅通过(O,O')-螯合模式与铂(II)离子配位,并且它们的Pt(II)配合物在水溶液中化学稳定。目前的N-取代氨基二羧酸的Pt(II)配合物对小鼠白血病L1210和人肿瘤细胞均表现出优异的抗肿瘤活性。特别是,高度疏水的N-邻苯二甲酰基谷氨酸配合物[Pt(dach)(PhthGlu)]对顺铂和卡铂无反应的人胃癌细胞表现出出色的体外活性(IC50 = 2.22 microM)。